Skip to main content
. Author manuscript; available in PMC: 2025 Jan 1.
Published in final edited form as: Eur J Surg Oncol. 2023 Nov 8;50(1):107252. doi: 10.1016/j.ejso.2023.107252

Table 3.

Comparison between baseline characteristics of MILR in 2118 Childs A vs 245 Childs B cirrhosis

Entire unmatched cohort 1:1 PSM (nearest neighbour matching) 1:1 CEM

All (N = 2363) Childs A (N =2118) Childs B (N = 245) P-value Childs A (N = 215) Childs B (N = 215) P-value (paried) Childs A (N = 191) Childs B (N = 191) P-value (paired)

Median age (IQR), yrs 63.00 [55.00, 71.00] 63.00 [55.00, 71.00] 61.00 [51.00, 69.00] 0.002 59.00 [52.10, 68.00] 61.00 [51.00, 70.00] 0.791 61.00 [53.00, 69.00] 60.00 [51.00, 68.95] 0.068

Male sex, n (%) 1760 (74.5) 1567 (74.0) 193 (78.8) 0.121 172 (80.0) 171 (79.5) 1.000 156 (81.7) 156 (81.7) NA

BMI 24.70 [22.28, 27.50] 24.70 [22.24, 27.52] 24.94 [22.48, 27.33] 0.873 24.16 [22.05, 26.65] 24.77 [22.43, 27.12] 0.275 24.72 [23.01, 27.19] 24.40 [22.15, 26.97] 0.113

Robotic, n (%) 260 (11.0) 221 (10.4) 39 (15.9) 36 (16.7) 33 (15.3) 23 (12.0) 23 (12.0)
Laparoscopic, n (%) 2103 (89.0) 1897 (89.6) 206 (84.1) 0.013 179 (83.3) 182 (84.7) 0.787 168 (88.0) 168 (88.0) NA

Previous abdominal surgery, n (%) 440 (19.5) 399 (19.8) 41 (17.2) 0.385 33 (15.3) 38 (17.7) 0.603 27 (14.1) 27 (14.1) NA

Year of surgery, n (%)
2004–2009 148 (6.3) 132 (6.2) 16 (6.5) 14 (6.5) 14 (6.5) 11 (5.8) 11 (5.8)
2010–2015 702 (29.7) 617 (29.1) 85 (34.7) 71 (33.0) 70 (32.6) 65 (34.0) 65 (34.0)
2016–2021 1513 (64.0) 1369 (64.6) 144 (58.8) 0.174 130 (60.5) 131 (60.9) 0.873 115 (60.2) 115 (60.2) NA

ASA score, n (%)
 1/2 1621 (68.7) 1454 (68.7) 167 (68.2) 138 (64.2) 147 (68.4) 135 (70.7) 135 (70.7)
 3/4 740 (31.3) 662 (31.3) 78 (31.8) 0.918 77 (35.8) 68 (31.6) 0.342 56 (29.3) 56 (29.3) NA

Tumor type, n (%)
 HCC 2225 (94.2) 1989 (94.0) 236 (96.3) 213 (99.1) 213 (99.1) 191 (100.0) 191 (100.0)
 ICC/ cholangiohepatoma 137 (5.8) 128 (6.0) 9 (3.7) 0.174 2 (0.9) 2 (0.9) 1.000 0 (0.0) 0 (0.0) NA

Median tumor size, mm (IQR) 26.00 [20.00, 38.00] 26.00 [20.00, 37.00] 30.00 [20.00, 45.00] 0.026 28.00 [20.00, 45.00] 30.00 [20.00, 45.00] 0.839 30.00 [20.00, 43.50] 30.00 [20.00, 45.00] 0.259

Multiple tumors, n (%) 230 (9.7) 206 (9.7) 24 (9.8) 1.000 15 (7.0) 17 (7.9) 0.855 5 (2.6) 5 (2.6) NA

Wedge/ partial liver resection, n (%) 1444 (61.1) 1319 (62.3) 125 (51.0) 99 (46.0) 116 (54.0) 97 (50.8) 97 (50.8)
Segmentectomy, n (%) 919 (38.9) 799 (37.7) 120 (49.0) 0.001 116 (54.0) 99 (46.0) 0.068 94 (49.2) 94 (49.2) NA

Concomitant minor surgery excluding cholecystectomy, n (%) 100 (4.2) 86 (4.1) 14 (5.7) 0.289 10 (4.7) 12 (5.6) 0.823 6 (3.1) 6 (3.1) NA

Hilar lymph node dissection, n (%) 10 (0.4) 9 (0.4) 1 (0.4) 1.000 2 (0.9) 1 (0.5) 1.000 0 (0.0) 0 (0.0) NA

Median Iwate difficulty score excluding Child score, [IQR] (range) 4.00 [2.00, 6.00] (1, 9) 4.00 [2.00, 6.00] (1, 9) 4.00 [2.00, 6.00] (1, 8) 0.046 4.00 [3.00, 6.00] (1, 8) 4.00 [2.00, 6.00] (1, 8) 0.293 4.00 [3.00, 6.00] (1, 8) 4.00 [3.00, 6.00] (1, 8) NA

Iwate difficulty exclude Child score, n (%)
 Low 1157 (49.0) 1055 (49.8) 102 (41.6) 87 (40.5) 94 (43.7) 80 (41.9) 80 (41.9)
 Intermediate 859 (36.4) 760 (35.9) 99 (40.4) 79 (36.7) 81 (37.7) 71 (37.2) 71 (37.2)
 High 346 (14.6) 302 (14.3) 44 (18.0) 0.043 49 (22.8) 40 (18.6) 0.507 40 (20.9) 40 (20.9) NA